Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.60
+0.08 (0.76%)
At close: Oct 9, 2026, 4:00 PM EDT
10.61
+0.01 (0.09%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Kura Oncology Market Cap
Kura Oncology has a market cap or net worth of $942.98 million as of October 9, 2026. It is the 10,634th most valuable company in the world and the 2,285th biggest in the United States. Its market cap has increased by 7.78% in one year.
Market Cap
942.98M
Enterprise Value
448.41M
1-Year Change
7.78%
Global Rank
Country Rank
#2,285 United States
Category
ChartMarket Cap Chart
Since November 5, 2015, Kura Oncology's market cap has increased from $113.70M to $942.98M, an increase of 729.36%. That is a compound annual growth rate of 21.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 942.98M | 4.30% |
| Dec 31, 2025 | 904.10M | 33.49% |
| Dec 31, 2024 | 677.30M | -36.58% |
| Dec 29, 2023 | 1.07B | 28.64% |
| Dec 30, 2022 | 830.20M | -10.90% |
| Dec 31, 2021 | 931.80M | -49.69% |
| Dec 31, 2020 | 1.85B | 197.24% |
| Dec 31, 2019 | 623.10M | 16.69% |
| Dec 31, 2018 | 534.00M | 15.51% |
| Dec 29, 2017 | 462.30M | 266.61% |
| Dec 30, 2016 | 126.10M | -29.75% |
| Dec 31, 2015 | 179.50M | 57.87% |
| Nov 5, 2015 | 113.70M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immatics | 1.02B |
| Latigo Biotherapeutics | 1.02B |
| Cullinan Therapeutics | 1.01B |
| Aktis Oncology | 1.01B |
| Seaport Therapeutics | 953.91M |
| MoonLake Immunotherapeutics | 942.13M |
| Adlai Nortye Group | 933.77M |
| Alto Neuroscience | 930.04M |